Two-drug combination proves effective for most lung cancers
New study suggests that using a two-drug combination of currently available treatment could be more effective for most lung cancers.
List view / Grid view
News
Researchers to investigate screening for prostate cancer using MRI
A new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accurately...
Genome sequencing of first 50,000 UK Biobank participants
UK Biobank has announced a major initiative to sequence the full genomes of 50,000 UK Biobank volunteer participants...
Larotrectinib shows promise in paediatric patients with TRK gene mutations
A new cancer drug has proven safe and effective for paediatric patients with a rare tumour gene mutation...
Flare-responsive hydrogel developed to treat arthritis
Researchers develop a better delivery system for anti-inflammatory therapies...
Are high-risk anticholinergic medicines prescribed too often for older adults?
Researchers are studying how frequently healthcare providers prescribe potentially inappropriate medications like anticholinergics to older adults.
FDA expands approval of Blincyto for treatment of B-cell precursor ALL
The FDA has granted accelerated approval to Blincyto to treat adults and children with B-cell precursor acute lymphoblastic leukaemia (ALL)...
Researchers develop injectable bandage to promote haemostasis
Researchers have used kappa-carrageenan and nanosilicates to form injectable hydrogels to promote haemostasis and facilitate wound healing...
Combination immunotherapy improves survival in mouse models of mesothelioma
Combined treatment with two cancer immunotherapy drugs significantly prolonged survival in aggressive cancer malignant mesothelioma...
Ionising radiation found to soften tumour cell microenvironment
When irradiated, less stiff extracellular matrices reduced cancer growth and migration, bolstering the case to further understand fractionated radiation therapy...
EC approves Alofisel for complex perianal fistulae in Crohn’s disease
The EC has approved Alofisel for the treatment of complex perianal fistulae in adult patients with nonactive/mildly active luminal Crohn’s disease...
INTEGRA – a driving force in pipetting innovation
INTEGRA is on a mission to revolutionise the world of pipetting, engaging with its customers to understand the challenges faced by today’s laboratories...
Anritsu capsule checkweighers deliver industry-leading weighing performance on your pharmaceutical production line
Anritsu's capsule checkweighers were developed and commercialised in 1970 ahead of others in the world, and ever since they have been used by many pharmaceutical manufacturers worldwide...
Oestrogen levels do not rise for transgender men treated with testosterone therapy
Testosterone therapy is not associated with a rise in oestrogen levels among transgender men, according to a new study led by Boston Medical Center...
Taking a standard prostate cancer drug with food boosts impact
By taking Zytiga with a low-fat meal could decrease the daily dose and prevent digestive issues...
